Planning for the Future: Building Inclusive Corporate Boards
1:45 PM - 2:45 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 203
Commitments to diversity, equity, and inclusion in the boardroom have been a priority in the biotech industry for several years. As lawmakers and the financial services industry advance legislation and proposals to support board diversity, legal challenges have increased. Biotech executives and investors must examine how companies in the industry can work towards more representation which ultimately supports the delivery of innovative treatments for patients. Attend this session to learn more about strategies and corporate governance best practices from investors, board members, and executives.
CEO; Managing Partner, Dana-Farber Cancer Institute; Professor
Kojin Therapeutics; Binney Street Capital (BSC); Harvard